Humes Jennifer 4

What Happened Jennifer Humes, Chief Accounting Officer of Roivant Sciences Ltd. (ROIV), reported the sale of 13,538 common shares on April 8, 2026. The transaction generated approximately $384,073 in proceeds at a weighted-average price of $28.37 per share. The filing lists the sale as open market or private sale (code S).

Key Details

• Transaction date: April 8, 2026; Form 4 filed April 10, 2026 (Accession No. 0001140361-26-014301). Filing appears to be within the normal two-business-day reporting window.
• Price: weighted average $28.37; individual trade prices ranged from $28.36 to $28.38 per footnote.
• Shares sold: 13,538; total proceeds ≈ $384,073.
• Shares owned after the transaction: not specified in the provided filing excerpt.
• Footnote: the reported price is a weighted average; reporting person can provide a breakdown of the number of shares sold at each price upon request.

Context This was a sale (often routine insider selling) and does not, by itself, indicate the insider’s view of the company’s prospects. No option exercise, gift, or tax-withholding event is noted in the provided details.